Progress in diagnosis and treatment of HNF1A-MODY
LUO Kuan-hong
WANG Zhi-hua
CHEN Yang
WANG Si-qi
WU Zhi-xin
LI Hui-qing
ZHENG Juan
Abstract:HNF1A-MODY is a type of maturity-onset diabetes of the young(MODY)caused by mutations in the liver nuclear factor 1A(HNF1A)gene,which accounts for about 1%to 3%of all types of diabetes.Due to the high heterogeneity of its clinical manifestations,it overlaps with the clinical features of type 1(T1DM)and type 2 diabetes mellitus(T2DM),and is easily missed or misdiagnosed as T1DM and T2DM.Therefore,early diagnosis helps to provide patients with safe and effective treatment options,improve long-term prognosis and quality of life,and reduce medical costs.Based on the research progress at home and abroad,this paper reviews the epidemiology,clinical features,and diagnosis and treatment strategies of HNF1A-MODY,aiming to provide evidence for the diagnosis of HNF1A-MODY,which is expected to provide help for its individualized treatment.
Keywords:monogenic diabetes mellitusHNF1A-MODYsulfonylureasdiagnosistreatment
Publication Date:2024-11-01
Online Publishing Date:2025-08-15(First online date of this platform, not the publication date of the document)
Pages:6( 911-916 )
Chinese Journal of Practical Internal Medicine

Chinese Journal of Practical Internal Medicine

ISTICPKUCSCD
ISSN:1005-2194
Year, Vol.(Issue):2024,44(11)